What are the major opportunities in the Meningococcal Disease Vaccine market? What are the strategies for the Meningococcal Disease Vaccine market?

For detailed insights on the major opportunities and strategies in the Meningococcal Disease Vaccine market, Read More

How does the Meningococcal Disease Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Meningococcal Disease Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Meningococcal Disease Vaccine market growth? SWOT analysis of the Meningococcal Disease Vaccine market.

For detailed insights on the key dynamics influencing the Meningococcal Disease Vaccine market growth and SWOT analysis of the Meningococcal Disease Vaccine industry, Read More

Meningococcal Disease Vaccine Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Meningococcal Disease Vaccine Market Report 2026

Name: Meningococcal Disease Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vaccine Type (Conjugate Vaccines, Polysaccharide Vaccines, Recombinant Vaccines, Live Attenuated Vaccines), By Age Group (Infants, Children, Adults, Older Adults), By Indication (Preventive Vaccination, Post-Exposure Prophylaxis, Travel-Related Vaccination, Outbreak Response), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Meningococcal Disease Vaccine Market Overview

• Meningococcal Disease Vaccine market size has reached to $2.59 billion in 2025

• Expected to grow to $4.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: Government Immunization Programs Fueling The Growth Of The Market Due To Increasing Access Awareness And Mandates

• Market Trend: Advancements In Meningococcal Disease Vaccine Development And Serogroup Coverage Expansion

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Meningococcal Disease Vaccine Market?

The meningococcal disease vaccine refers to a vaccine that protects against meningococcal disease, a serious bacterial infection caused by the bacterium Neisseria meningitidis. This disease can lead to meningitis (inflammation of the membranes around the brain and spinal cord) and septicemia (blood poisoning), both of which can be life-threatening.

The main types of meningococcal disease vaccines are conjugate vaccines, polysaccharide vaccines, recombinant vaccines, and live attenuated vaccines. Conjugate vaccines enhance immunity by linking bacterial sugars to proteins, offering effective protection against strains A, C, W, and Y, especially for adolescents and high-risk individuals. It is specifically available for various age groups, such as infants, children, adults, and older adults, for several indications, including preventive vaccination, post-exposure prophylaxis, travel-related vaccination, and outbreak response. It is distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and is used by various end-users including hospitals, specialty clinics, home care, and others.

Meningococcal Disease Vaccine Market Global Report 2026 Market Report bar graph

What Is The Meningococcal Disease Vaccine Market Size and Share 2026?

The meningococcal disease vaccine market size has grown strongly in recent years. It will grow from $2.59 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to recurring meningococcal disease outbreaks, high mortality and morbidity rates, government-supported vaccination programs, increased awareness of bacterial meningitis, expansion of pediatric immunization schedules.

What Is The Meningococcal Disease Vaccine Market Growth Forecast?

The meningococcal disease vaccine market size is expected to see strong growth in the next few years. It will grow to $4.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising global travel and migration, increasing focus on preventive healthcare, expansion of vaccine coverage in emerging economies, growth in adolescent immunization initiatives, advancement in vaccine research and development. Major trends in the forecast period include rising adoption of conjugate and recombinant vaccines, expansion of routine immunization programs, increasing focus on adolescent and adult vaccination, growth in travel-related and outbreak-driven vaccination, higher emphasis on early preventive immunization.

Book your 30 minutes free consultation with our research experts

Global Meningococcal Disease Vaccine Market Segmentation

1) By Vaccine Type: Conjugate Vaccines, Polysaccharide Vaccines, Recombinant Vaccines, Live Attenuated Vaccines

2) By Age Group: Infants, Children, Adults, Older Adults

3) By Indication: Preventive Vaccination, Post-Exposure Prophylaxis, Travel-Related Vaccination, Outbreak Response

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Conjugate Vaccines: Monovalent Conjugate Vaccines, Quadrivalent Conjugate Vaccines, Pediatric Conjugate Vaccines, Adolescent Or Adult Conjugate Vaccines

2) By Polysaccharide Vaccines: Bivalent Polysaccharide Vaccines, Trivalent Polysaccharide Vaccines, Quadrivalent Polysaccharide Vaccines, Age-Specific Polysaccharide Formulations

3) By Recombinant Vaccines: Serogroup B Recombinant Protein Vaccines, Multicomponent Recombinant Vaccines, Outer Membrane Vesicle (OMV) Based Recombinant Vaccines

4) By Live Attenuated Vaccines: Experimental Intranasal Live Attenuated Vaccines, Genetically Engineered Attenuated Strain Vaccines, Combined Live Attenuated Vaccines

What Is The Driver Of The Meningococcal Disease Vaccine Market?

The increasing government immunization programs are expected to propel the growth of the meningococcal disease vaccine market going forward. Government immunization programs are health initiatives that offer free or low-cost vaccines to safeguard communities against infectious diseases. Government immunization programs are growing due to a heightened emphasis on preventing infectious diseases and alleviating healthcare burdens through widespread vaccinations. Government immunization programs drive the growth of meningococcal vaccines by expanding access and increasing vaccination rates while raising awareness and reducing disease incidence. They also create demand by mandating vaccinations and promoting public health. For instance, in April 2024, according to the Pan American Health Organization (PAHO), a US-based specialized agency, the 22nd Vaccination Week in the Americas (VWA), with the theme Engage now to protect your future. GetVax was launched aiming to increase vaccination coverage, especially in underserved areas, by administering over 65 million doses. The initiative focused on combating misinformation and enhancing access to vaccines through community engagement and tailored campaigns. Therefore, the increasing government immunization programs driving the growth of the meningococcal disease vaccine industry.

Key Players In The Global Meningococcal Disease Vaccine Market

Major companies operating in the meningococcal disease vaccine market are Pfizer Inc, Merck & Co Inc, Sanofi SA, GlaxoSmithKline plc, Serum Institute of India Pvt Ltd, Biovac Institute, Bio Manguinhos, Finlay Institute of Vaccines, Walvax Biotechnology Co Ltd, CSL Limited, China National Biotec Group, Hualan Biological Engineering Inc, Chongqing Zhifei Biological Products Co Ltd, Hangzhou Jinjiang Group Co Ltd, Shenzhen Kangtai Biological Products Co Ltd, Panacea Biotec, Biological E Limited, Instituto Butantan, Incepta Pharmaceuticals Ltd, Bio Med Pvt Ltd, Bharat Biotech International Ltd, Zhejiang Tianyuan Bio Pharmaceutical Co Ltd, Beijing Tiantan Biological Products Co Ltd.

Global Meningococcal Disease Vaccine Market Trends and Insights

Major companies operating in the meningococcal disease vaccine market are focused on developing advanced products, such as pentavalent meningococcal vaccines, to expand serogroup coverage, streamline immunization schedules, and improve disease prevention. A pentavalent meningococcal vaccine is an advanced immunization solution that targets five major serogroups of Neisseria meningitidis in a single dose, reducing the need for multiple separate vaccinations and improving compliance. For instance, in October 2023, Pfizer Inc., a US-based biopharmaceutical company, announced the Food and Drug Administration (FDA) approval for PENBRAYA, the first and only vaccine for the prevention of meningococcal disease in individuals aged 10 to 25 years. This innovative vaccine combines components from two existing meningococcal vaccines, Trumenba and Nimenrix, to protect against the five most common serogroups (A, B, C, W, and Y) of Neisseria meningitidis that cause the majority of invasive meningococcal disease (IMD) globally. PENBRAYA represents a significant advancement in meningococcal disease prevention, offering the broadest serogroup coverage of any meningococcal vaccine available in the U.S. and potentially simplifying the vaccination schedule by reducing the total number of doses required for full protection.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Meningococcal Disease Vaccine Market?

In September 2023, Biovac, a South Africa-based biopharmaceutical company, partnered with EuBiologics Co. Ltd. to empower Africa through local vaccine innovation and self-reliance. The partnership aims to transfer technology and locally manufacture meningococcal meningitis pentavalent conjugate vaccine in Africa, addressing critical health needs in the meningitis belt and advancing the continent’s vaccine self-sufficiency. EuBiologics Co., Ltd. is a South Korea-based manufacturer of pentavalent meningococcal conjugate vaccine.

Regional Outlook

North America was the largest region in the meningococcal disease vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Meningococcal Disease Vaccine Market?

The meningococcal disease vaccine market consists of sales of protein-based vaccines, outer membrane vesicle (OMV) vaccines, and multicomponent vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Meningococcal Disease Vaccine Market Report 2026?

The meningococcal disease vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the meningococcal disease vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Meningococcal Disease Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.84 billion
Revenue Forecast In 2035	$4.11 billion
Growth Rate	CAGR of 9.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vaccine Type, Age Group, Indication, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc, Merck & Co Inc, Sanofi SA, GlaxoSmithKline plc, Serum Institute of India Pvt Ltd, Biovac Institute, Bio Manguinhos, Finlay Institute of Vaccines, Walvax Biotechnology Co Ltd, CSL Limited, China National Biotec Group, Hualan Biological Engineering Inc, Chongqing Zhifei Biological Products Co Ltd, Hangzhou Jinjiang Group Co Ltd, Shenzhen Kangtai Biological Products Co Ltd, Panacea Biotec, Biological E Limited, Instituto Butantan, Incepta Pharmaceuticals Ltd, Bio Med Pvt Ltd, Bharat Biotech International Ltd, Zhejiang Tianyuan Bio Pharmaceutical Co Ltd, Beijing Tiantan Biological Products Co Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Meningococcal Disease Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Meningococcal Disease Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Meningococcal Disease Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Meningococcal Disease Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Conjugate And Recombinant Vaccines

4.2.2 Expansion Of Routine Immunization Programs

4.2.3 Increasing Focus On Adolescent And Adult Vaccination

4.2.4 Growth In Travel-Related And Outbreak-Driven Vaccination

4.2.5 Higher Emphasis On Early Preventive Immunization

5. Meningococcal Disease Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Vaccination Centers

5.4 Public Health Agencies

5.5 Homecare Immunization Providers

6. Meningococcal Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Meningococcal Disease Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Meningococcal Disease Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Meningococcal Disease Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Meningococcal Disease Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Meningococcal Disease Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Meningococcal Disease Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Meningococcal Disease Vaccine Market Segmentation

9.1. Global Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conjugate Vaccines, Polysaccharide Vaccines, Recombinant Vaccines, Live Attenuated Vaccines

9.2. Global Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infants, Children, Adults, Older Adults

9.3. Global Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preventive Vaccination, Post-Exposure Prophylaxis, Travel-Related Vaccination, Outbreak Response

9.4. Global Meningococcal Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

9.5. Global Meningococcal Disease Vaccine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End-Users

9.6. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monovalent Conjugate Vaccines, Quadrivalent Conjugate Vaccines, Pediatric Conjugate Vaccines, Adolescent Or Adult Conjugate Vaccines

9.7. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Polysaccharide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bivalent Polysaccharide Vaccines, Trivalent Polysaccharide Vaccines, Quadrivalent Polysaccharide Vaccines, Age-Specific Polysaccharide Formulations

9.8. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serogroup B Recombinant Protein Vaccines, Multicomponent Recombinant Vaccines, Outer Membrane Vesicle (OMV) Based Recombinant Vaccines

9.9. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Experimental Intranasal Live Attenuated Vaccines, Genetically Engineered Attenuated Strain Vaccines, Combined Live Attenuated Vaccines

10. Meningococcal Disease Vaccine Market Regional And Country Analysis

10.1. Global Meningococcal Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Meningococcal Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Meningococcal Disease Vaccine Market

11.1. Asia-Pacific Meningococcal Disease Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Meningococcal Disease Vaccine Market

12.1. China Meningococcal Disease Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Meningococcal Disease Vaccine Market

13.1. India Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Meningococcal Disease Vaccine Market

14.1. Japan Meningococcal Disease Vaccine Market Overview

14.2. Japan Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Meningococcal Disease Vaccine Market

15.1. Australia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Meningococcal Disease Vaccine Market

16.1. Indonesia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Meningococcal Disease Vaccine Market

17.1. South Korea Meningococcal Disease Vaccine Market Overview

17.2. South Korea Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Meningococcal Disease Vaccine Market

18.1. Taiwan Meningococcal Disease Vaccine Market Overview

18.2. Taiwan Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Meningococcal Disease Vaccine Market

19.1. South East Asia Meningococcal Disease Vaccine Market Overview

19.2. South East Asia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Meningococcal Disease Vaccine Market

20.1. Western Europe Meningococcal Disease Vaccine Market Overview

20.2. Western Europe Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Meningococcal Disease Vaccine Market

21.1. UK Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Meningococcal Disease Vaccine Market

22.1. Germany Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Meningococcal Disease Vaccine Market

23.1. France Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Meningococcal Disease Vaccine Market

24.1. Italy Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Meningococcal Disease Vaccine Market

25.1. Spain Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Meningococcal Disease Vaccine Market

26.1. Eastern Europe Meningococcal Disease Vaccine Market Overview

26.2. Eastern Europe Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Meningococcal Disease Vaccine Market

27.1. Russia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Meningococcal Disease Vaccine Market

28.1. North America Meningococcal Disease Vaccine Market Overview

28.2. North America Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Meningococcal Disease Vaccine Market

29.1. USA Meningococcal Disease Vaccine Market Overview

29.2. USA Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Meningococcal Disease Vaccine Market

30.1. Canada Meningococcal Disease Vaccine Market Overview

30.2. Canada Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Meningococcal Disease Vaccine Market

31.1. South America Meningococcal Disease Vaccine Market Overview

31.2. South America Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Meningococcal Disease Vaccine Market

32.1. Brazil Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Meningococcal Disease Vaccine Market

33.1. Middle East Meningococcal Disease Vaccine Market Overview

33.2. Middle East Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Meningococcal Disease Vaccine Market

34.1. Africa Meningococcal Disease Vaccine Market Overview

34.2. Africa Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Meningococcal Disease Vaccine Market Regulatory and Investment Landscape

36. Meningococcal Disease Vaccine Market Competitive Landscape And Company Profiles

36.1. Meningococcal Disease Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Meningococcal Disease Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Meningococcal Disease Vaccine Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Serum Institute of India Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Meningococcal Disease Vaccine Market Other Major And Innovative Companies

Biovac Institute, Bio-Manguinhos, Finlay Institute of Vaccines, Walvax Biotechnology Co Ltd, CSL Limited, China National Biotec Group, Hualan Biological Engineering Inc, Chongqing Zhifei Biological Products Co Ltd, Hangzhou Jinjiang Group Co Ltd, Shenzhen Kangtai Biological Products Co Ltd, Panacea Biotec, Biological E Limited, Instituto Butantan, Incepta Pharmaceuticals Ltd, Bio-Med Pvt Ltd

38. Global Meningococcal Disease Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Meningococcal Disease Vaccine Market

40. Meningococcal Disease Vaccine Market High Potential Countries, Segments and Strategies

40.1 Meningococcal Disease Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Meningococcal Disease Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Meningococcal Disease Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Meningococcal Disease Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Meningococcal Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Meningococcal Disease Vaccine Market, Supply Chain Analysis

Table 4: Global Meningococcal Disease Vaccine Market, Major Raw Material Providers

Table 5: Global Meningococcal Disease Vaccine Market, Major Resource Providers

Table 6: Global Meningococcal Disease Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Meningococcal Disease Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Meningococcal Disease Vaccine Market, Key Technologies & Future Trends

Table 9: Global Meningococcal Disease Vaccine Market, Major Trends

Table 10: Global Meningococcal Disease Vaccine Market, Major End Users

Table 11: Global Meningococcal Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Meningococcal Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Meningococcal Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Meningococcal Disease Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Meningococcal Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Meningococcal Disease Vaccine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Polysaccharide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Meningococcal Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Meningococcal Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Meningococcal Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Meningococcal Disease Vaccine Market - Company Scoring Matrix

Table 100: Pfizer Inc Financial Performance

Table 101: Merck & Co Inc Financial Performance

Table 102: Sanofi SA Financial Performance

Table 103: GlaxoSmithKline plc Financial Performance

Table 104: Serum Institute of India Pvt Ltd Financial Performance

Table 105: Global Meningococcal Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Meningococcal Disease Vaccine Market, Competitive Dashboard

Table 107: Global Meningococcal Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Table 109: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Table 110: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

Figure 1: Global Meningococcal Disease Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Meningococcal Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Meningococcal Disease Vaccine Market, Supply Chain Analysis

Figure 4: Global Meningococcal Disease Vaccine Market, Major Raw Material Providers

Figure 5: Global Meningococcal Disease Vaccine Market, Major Resource Providers

Figure 6: Global Meningococcal Disease Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Meningococcal Disease Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Meningococcal Disease Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Meningococcal Disease Vaccine Market, Major Trends

Figure 10: Global Meningococcal Disease Vaccine Market, Major End Users

Figure 11: Global Meningococcal Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Meningococcal Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Meningococcal Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Meningococcal Disease Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Meningococcal Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Meningococcal Disease Vaccine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Polysaccharide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Meningococcal Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Meningococcal Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Meningococcal Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Meningococcal Disease Vaccine Market - Company Scoring Matrix

Figure 100: Pfizer Inc Financial Performance

Figure 101: Merck & Co Inc Financial Performance

Figure 102: Sanofi SA Financial Performance

Figure 103: GlaxoSmithKline plc Financial Performance

Figure 104: Serum Institute of India Pvt Ltd Financial Performance

Figure 105: Global Meningococcal Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Meningococcal Disease Vaccine Market, Competitive Dashboard

Figure 107: Global Meningococcal Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Figure 109: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Figure 110: Global, Meningococcal Disease Vaccine Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Protective Relays And Circuit Breakers Market Report 2026 - Global Outlook – By Type ( Protective Relays, Circuit Breakers), By Voltage Rating ( Low Voltage (Up To 1kV), Medium Voltage (1kV – 69kV), High Voltage (Above 6...

Adult Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Con...

Meningococcal Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Childre...

Meningococcal Disease Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Conjugate Vaccines, Polysaccharide Vaccines, Recombinant Vaccines, Live Attenuated Vaccines), By Age Group (Infants, Children, Adults, ...

Pneumococcal Vaccine Market Report 2026 - Global Outlook – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Chan...

Frequently Asked Questions

How big is the Meningococcal Disease Vaccine Market?

The Meningococcal Disease Vaccine market was valued at $2.59 billion in 2025, increased to $2.84 billion in 2026, and is projected to reach $4.11 billion by 2030.

What is the Meningococcal Disease Vaccine market growth?

The global Meningococcal Disease Vaccine market is expected to grow at a CAGR of 9.6% from 2026 to 2035 to reach $4.11 billion by 2035.

Who are the key players in Meningococcal Disease Vaccine market?

Some Key Players in the Meningococcal Disease Vaccine market Include, Pfizer Inc, Merck & Co Inc, Sanofi SA, GlaxoSmithKline plc, Serum Institute of India Pvt Ltd, Biovac Institute, Bio Manguinhos, Finlay Institute of Vaccines, Walvax Biotechnology Co Ltd, CSL Limited, China National Biotec Group, Hualan Biological Engineering Inc, Chongqing Zhifei Biological Products Co Ltd, Hangzhou Jinjiang Group Co Ltd, Shenzhen Kangtai Biological Products Co Ltd, Panacea Biotec, Biological E Limited, Instituto Butantan, Incepta Pharmaceuticals Ltd, Bio Med Pvt Ltd, Bharat Biotech International Ltd, Zhejiang Tianyuan Bio Pharmaceutical Co Ltd, Beijing Tiantan Biological Products Co Ltd. .

What is the anticipated growth trend for the Meningococcal Disease Vaccine market?

Major trend in this market includes: Advancements In Meningococcal Disease Vaccine Development And Serogroup Coverage Expansion. For further insights on this market. request a sample here

Which region has the most growth potential in the Meningococcal Disease Vaccine market?

North America was the largest region in the meningococcal disease vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the meningococcal disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.